Skip to main content
VRCA
NASDAQ Life Sciences

YCANTH Revenue Jumps 57.9% to $5.7M as Verrica Secures $27.5M Growth Capital

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$3.71
Mkt Cap
$63.905M
52W Low
$3.08
52W High
$9.821
52W Position info
20% above low
Off High info
62% below high
Rel. Volume info
1.4× avg
Market data snapshot near publication time

VRCA sits 20% above its 52-week low of $3.08.

Summary

Verrica reported Q3 2026 YCANTH net product revenue of $5.7M, up 57.9% year over year and 11.9% from the prior quarter, with total revenue of $6.9M. The company also unlocked access to $27.5M in growth capital and says cash now funds operations through both common-warts Phase 3 trial readouts. That matters because the last 10-Q carried a going concern warning and a $13.2M quarterly net loss, so the financing plus revenue ramp directly addresses the survival question. The first pivotal common-warts trial (COVE-2) has completed enrollment, with topline data expected Q1 2027 and the second trial's data mid-2027. Watch those readouts — they are the binary events for the equity.

At the time of this announcement, VRCA was trading at $3.71 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $63.9M. The 52-week trading range was $3.08 to $9.82. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

VRCA - Latest Insights

VRCA
Nov 12, 2026, 4:27 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.71
Real-time Price: $3.71 info
Change: $0 (0%) info
Market Cap: $63.905M info
VRCA
Aug 27, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $4.76
Real-time Price: $3.71 info
Change: -$1.05 (-22%) info
Market Cap: $63.905M info
VRCA
Aug 18, 2026, 5:00 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $4.68
Real-time Price: $3.71 info
Change: -$0.970 (-21%) info
Market Cap: $63.905M info
VRCA
Aug 06, 2026, 4:37 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $5.36
Real-time Price: $3.71 info
Change: -$1.65 (-31%) info
Market Cap: $63.905M info
VRCA
Aug 06, 2026, 4:34 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $5.36
Real-time Price: $3.71 info
Change: -$1.65 (-31%) info
Market Cap: $63.905M info